Literature DB >> 9824774

Binding of matrix metalloproteinase 9 to fibrin is mediated by amorphous calcium-phosphate.

G S Makowski1, M L Ramsby.   

Abstract

In our previous study we demonstrated selective, dose-dependent binding of matrix metalloproteinase-9 (MMP-9), a neutrophil collagenase, to fibrin. Here we investigated the mechanism of this interaction. We found that MMP-9 to fibrin was dependent on formation of a calcium-phosphate intermediate. The intermediate was precipitable by centrifugation and contained a Ca/P ratio of 1.52-1.54, consistent with amorphous calcium-phosphate (ACP). ACP formation exhibited a temperature optimum at 37 degrees C. Gelatin zymography revealed that interaction of ACP with MMP-9 resulted in formation of a high molecular weight ACP:MMP-9 complex which was required for MMP-9 binding to fibrin. Complex formation was dependent on the generation of viable ACP that required both calcium (7.5-10 mM) and phosphate (225-250 microM) (Ca x P product range, 1.7-2.5 mM2). Carbonate (CO3) and sulfate (SO4) were ineffective as calcium counteranions. Preformed ACP rapidly complexed MMP-9. Thus ACP formation was rate-limiting for MMP-9 fibrin binding activity. No MMP-9 fibrin binding activity was noted at 25 degrees C, an observation consistent with lack of ACP production. The significance of these findings is discussed with respect to normal and pathologic wound healing.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9824774     DOI: 10.1023/a:1022314530777

Source DB:  PubMed          Journal:  Inflammation        ISSN: 0360-3997            Impact factor:   4.092


  55 in total

1.  Tissue inhibitors of matrix metalloendopeptidases.

Authors:  G Murphy; F Willenbrock
Journal:  Methods Enzymol       Date:  1995       Impact factor: 1.600

2.  Calibrating gelatin zymograms with human gelatinase standards.

Authors:  G S Makowski; M L Ramsby
Journal:  Anal Biochem       Date:  1996-05-01       Impact factor: 3.365

3.  Urokinase plasminogen activator and gelatinases are associated with membrane vesicles shed by human HT1080 fibrosarcoma cells.

Authors:  A Ginestra; S Monea; G Seghezzi; V Dolo; H Nagase; P Mignatti; M L Vittorelli
Journal:  J Biol Chem       Date:  1997-07-04       Impact factor: 5.157

4.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

5.  Acidic amino acid-rich sequences as binding sites of osteonectin to hydroxyapatite crystals.

Authors:  R Fujisawa; Y Wada; Y Nodasaka; Y Kuboki
Journal:  Biochim Biophys Acta       Date:  1996-01-04

6.  Measurement of O2- production by human neutrophils. The preparation and assay of NADPH oxidase-containing particles from human neutrophils.

Authors:  M Markert; P C Andrews; B M Babior
Journal:  Methods Enzymol       Date:  1984       Impact factor: 1.600

7.  Effect of plasminogen activator (urokinase), plasmin, and thrombin on glycoprotein and collagenous components of basement membrane.

Authors:  L A Liotta; R H Goldfarb; R Brundage; G P Siegal; V Terranova; S Garbisa
Journal:  Cancer Res       Date:  1981-11       Impact factor: 12.701

Review 8.  Activation mechanisms of matrix metalloproteinases.

Authors:  H Nagase
Journal:  Biol Chem       Date:  1997 Mar-Apr       Impact factor: 3.915

9.  Biochemical and immunological characterization of the secreted forms of human neutrophil gelatinase.

Authors:  M S Hibbs; K A Hasty; J M Seyer; A H Kang; C L Mainardi
Journal:  J Biol Chem       Date:  1985-02-25       Impact factor: 5.157

10.  Membrane-type matrix metalloproteinase (MT-MMP) gene is expressed in stromal cells of human colon, breast, and head and neck carcinomas.

Authors:  A Okada; J P Bellocq; N Rouyer; M P Chenard; M C Rio; P Chambon; P Basset
Journal:  Proc Natl Acad Sci U S A       Date:  1995-03-28       Impact factor: 11.205

View more
  4 in total

1.  Interaction of amorphous calcium phosphate with fibrin in vitro causes decreased fibrinolysis and altered protease profiles: implications for atherosclerotic disease.

Authors:  G S Makowski; M L Ramsby
Journal:  Inflammation       Date:  2001-10       Impact factor: 4.092

2.  Amorphous calcium phosphate-mediated binding of matrix metalloproteinase-9 to fibrin is inhibited by pyrophosphate and bisphosphonate.

Authors:  G S Makowski; M L Ramsby
Journal:  Inflammation       Date:  1999-08       Impact factor: 4.092

Review 3.  Matrix metalloproteinase contribution in management of cancer proliferation, metastasis and drug targeting.

Authors:  Nabil M Abdel-Hamid; Shimaa A Abass
Journal:  Mol Biol Rep       Date:  2021-08-11       Impact factor: 2.316

4.  Differential effect of calcium phosphate and calcium pyrophosphate on binding of matrix metalloproteinases to fibrin: comparison to a fibrin-binding protease from inflammatory joint fluids.

Authors:  G S Makowski; M L Ramsby
Journal:  Clin Exp Immunol       Date:  2004-04       Impact factor: 4.330

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.